Recalcitrant pyoderma gangrenosum: Treatment with thalidomide

被引：43

作者：

Hecker, MS ^{[1
]}

Lebwohl, MG ^{[1
]}

机构：

[1] Mt Sinai Med Ctr, Dept Dermatol, New York, NY 10029 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1998年 / 38卷 / 03期

关键词：

D O I：

10.1016/S0190-9622(98)70513-4

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：490 / 491

页数：2

共 14 条

[1] THALIDOMIDE - USE AND POSSIBLE MODE OF ACTION IN REACTIONAL LEPROMATOUS LEPROSY AND IN VARIOUS OTHER CONDITIONS [J].

BARNHILL, RL ;

MCDOUGALL, AC .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1982, 7 (03) :317-323

[2]

DARCY PF, 1994, ADVERSE DRUG REACT T, V13, P65

[3] INHIBITION OF PMN LEUKOCYTES CHEMOTAXIS BY THALIDOMIDE [J].

FAURE, M ;

THIVOLET, J ;

GAUCHERAND, M .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 1980, 269 (03) :275-280

[4]

FULLERTON PM, 1961, BRIT MED J, V1, P130

[5] PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE [J].

HELLMANN, K ;

DUKE, DI ;

TUCKER, DF .

BRITISH MEDICAL JOURNAL, 1965, 2 (5463) :687-&

[6]

Koch H P, 1985, Prog Med Chem, V22, P165, DOI 10.1016/S0079-6468(08)70231-5

[7]

MELLIN G W, 1962, N Engl J Med, V267, P1184, DOI 10.1056/NEJM196212062672305

[8] THALIDOMIDE EXERTS ITS INHIBITORY-ACTION ON TUMOR-NECROSIS-FACTOR-ALPHA BY ENHANCING MESSENGER-RNA DEGRADATION [J].

MOREIRA, AL ;

SAMPAIO, EP ;

ZMUIDZINAS, A ;

FRINDT, P ;

SMITH, KA ;

KAPLAN, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1675-1680

[9]

MUNRO CS, 1988, CLIN EXP DERMATOL, V13, P408

[10] GUIDELINE FOR THE CLINICAL USE AND DISPENSING OF THALIDOMIDE [J].

POWELL, RJ ;

GARDNERMEDWIN, JMM .

POSTGRADUATE MEDICAL JOURNAL, 1994, 70 (830) :901-904

← 1 2 →